Sechenov School
Home › Pathology › Cholangiocarcinoma

Cholangiocarcinoma

*Cholangiocarcinoma*

For medical students2 min readUpdated 2026-10-10

Cholangiocarcinoma (also known as bile duct cancer) is a malignant tumor originating from the biliary tract epithelium. The disease is characterized by the formation of dense nodules with a prominent stroma and requires careful differential diagnosis with metastases from other carcinomas.

Cell of originEpithelial lining of the bile ducts
Risk groupPredominantly patients over 60 years of age
HistologyAtypical cuboidal or tall columnar epithelium
EtiologyAssociated with *Opisthorchis* infection and thorium dioxide (thorotrast) exposure
Specific featurePronounced mucin production within tumor cells

Epidemiology, Geography, and Etiological Factors

Cholangiocarcinoma represents a major challenge in oncopathology. Compared to hepatocellular carcinoma (HCC), another primary liver malignancy, this tumor is significantly less common in the population. The primary patient demographic consists of older adults, with the disease typically diagnosed in individuals over sixty.

An interesting feature of this pathology is its marked geographic distribution. The disease is reported with much higher frequency in Eastern countries. This epidemiological pattern has a clear etiological explanation: parasitic infections are widespread in eastern regions, specifically infestation with the parasite Opisthorchis sinensis, which infects the biliary tract. Long-standing opisthorchiasis acts as a potent risk factor that triggers malignant transformation of the epithelium.

In addition to parasitic infestation, the historical use of thorotrast played an important role in pathogenesis. This special contrast agent proved to be carcinogenic and capable of inducing bile duct cancer.

Macroscopic and Microscopic Morphology

Macroscopically, when examining the affected organ, the pathologist typically discovers a characteristic tumor lesion. Visually, it presents as a very dense, whitish nodule. Notably, multicentric growth is possible in this carcinoma, meaning that multiple independent centers of malignant growth may form within the tissue.

Microscopic structure of the tumor is diverse yet follows distinct patterns. Under the microscope, the following features are determined:

Diagnostic Challenges and Metastatic Pathways

Establishing an accurate diagnosis requires high vigilance from the pathologist. The main challenge is that histologically, cholangiocarcinoma strikingly resembles classical adenocarcinoma developing in other internal organs.

Due to this phenomenal resemblance, differential diagnosis becomes a critical step. The physician must definitively rule out secondary (metastatic) liver involvement. Before diagnosing primary bile duct cancer, a thorough search for a possible primary adenocarcinoma in other locations is performed. Only after confirming the absence of another source can the primary nature of the tumor be verified.

Mnemonic

To easily recall the microscopic features, use the rule of the "Three M's": Mucin (characteristic mucus production), Matrix/Stroma (wide connective tissue septa), and Morphology/Structures (glandular, papillary, and tubular structures).

Frequently asked questions

What etiological factors and precancerous conditions lead to the development of cholangiocarcinoma?

Etiological factors and precancerous conditions for cholangiocarcinoma include parasitic infections, contrast agents, and chronic biliary tract pathologies.

  • Opisthorchiasis (Opisthorchis sinensis) — causes adenomatous hyperplasia of the bile duct epithelium, considered a background lesion.
  • Thorotrast exposure — the use of this contrast agent is a known risk factor.
  • Caroli disease — a congenital condition predisposing adults to tumor development.
  • Primary sclerosing cholangitis — leads to carcinoma in 10–15% of patients.
  • Recurrent pyogenic cholangitis — acts as a long-term complication.
What macroscopic growth forms are distinguished in cholangiocarcinoma?

Macroscopically, cholangiocarcinoma most often presents as a dense, whitish nodule. Furthermore, this malignant neoplasm may exhibit a multicentric growth pattern, where multiple tumor foci form within the liver simultaneously. The tumor develops from the biliary epithelium and is accompanied by a well-developed stroma with broad connective tissue septa.

With which malignant neoplasms is cholangiocarcinoma differentially diagnosed?

Differential diagnosis of cholangiocarcinoma is primarily performed against metastatic liver disease. Because the tumor histologically resembles adenocarcinoma of other organs, the presence of a primary adenocarcinoma elsewhere must be ruled out. Immunohistochemical staining is the primary method used to clarify the diagnosis, especially to exclude gastrointestinal metastases when evaluating combined expression of CK20, CK7, and CK19.

Which immunohistochemical markers are expressed by cholangiocarcinoma?

Cholangiocarcinoma expresses various immunohistochemical markers depending on the histological type. Typically, neoplasms are positive for cytokeratins 7 and 19, as well as mucin 1.

Adenocarcinoma TypeExpressed Markers
Biliary typeCEA, mucins 1 and 2, p53, cytokeratin 7, S100P, TFF1, AGR2
Cholangiolar typeCEA, mucin 2, cytokeratin 20, N-cadherin

Focal expression of cytokeratin 20 may also be observed. Currently, there is no single specific stain to definitively verify the tumor.

Which parasite species are associated with an increased risk of cholangiocarcinoma?

Parasitic infections of the biliary tract are linked to cholangiocarcinoma.

  • Opisthorchis sinensis — causes adenomatous hyperplasia of the bile duct epithelium, considered a background change for cholangiocarcinoma.
  • Clonorchis sinensis — may play a role in the pathogenesis of recurrent pyogenic cholangitis, a long-term complication of which can be cholangiocarcinoma.
Which genetic mutations are most characteristic of intrahepatic cholangiocarcinoma?

Intrahepatic cholangiocarcinoma is characterized by activating mutations found in up to 40% of cases.

  • KRAS mutation — detected in 23% of cases in the biliary tumor type and only 1% in the cholangiolar type.
  • NTRK and FGFR1-4 gene translocations — detection is mandatory for selecting molecular-targeted therapy.
  • BRAF/RAS co-mutations — presence significantly reduces the efficacy of targeted anti-HER2 therapy.
How common is this tumor compared to other primary liver cancers?

Cholangiocarcinoma is diagnosed less frequently than hepatocellular carcinoma (HCC).

Why is the disease more commonly reported in Eastern countries?

This is directly related to the high endemic prevalence of parasitic infestation with Opisthorchis sinensis, which infects the bile ducts.

What is the main challenge during microscopic examination of a biopsy?

Histologically, the tumor looks like a typical adenocarcinoma, making it extremely difficult to visually distinguish primary bile duct cancer from metastatic adenocarcinoma originating in other organs.

What pathways are involved in the metastasis of bile duct cancer?

The tumor is capable of spreading throughout the body via both classical pathways: lymphatic and hematogenous.

Go deeper

More topics in Pathology

Morphology of Tumor GrowthSepsisSodium, Potassium and Copper Metabolism DisordersProductive InflammationAortic Valve DiseasePneumoconioses and SilicosisAcute Lymphoblastic LeukemiaTumor-Host InteractionGranulomatous InflammationHeart Transplantation: Pathology, Rejection, and ComplicationsMyeloma KidneyGastritis: Acute and Chronic Forms, OLGA SystemPathology →